Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaven Grwth 3 Regulatory News (MIG3)

Share Price Information for Maven Grwth 3 (MIG3)

Share Price is delayed by 15 minutes
Get Live Data
42.40    0.00 (0.00%)
Bid:
41.40
Ask:
43.40
Spread: 2.00 (4.831%)
Market Cap: £66.18m
MIG3 Live PriceLast checked at - London Stock Exchange

Intraday Maven Grwth 3 Share Chart

Statement re Offer for Subscription

30 Apr 2014 07:01

RNS Number : 8462F
Maven Income and Growth VCT 3 PLC
30 April 2014
Β 

ο»Ώ

Maven Income and Growth VCT 3 plc (the "Company")

Β 

Extension to Offer for Subscription

Β 

On 24 October 2013, the Company, Maven Income and Growth VCT plc, Maven Income and Growth VCT 2 plc, Maven Income and Growth VCT 4 plc, Maven Income and Growth VCT 5 plc and Maven Income and Growth VCT 6 plc (together "the Companies") announced that they had published a Prospectus (comprising a Securities Note, Registration Document and Summary) in relation to offers for subscription for new Ordinary Shares in each of the Companies to raise, in aggregate, up to Β£20 million (before issue costs) together with an over-allotment facility for up to a further Β£5 million, in aggregate (the "Offer").

Β 

The Offer closed on 5 April 2014 in relation to the tax year 2013/14 and was intended to close on 30 April 2014 in relation to the tax year 2014/15 unless fully subscribed by an earlier date or previously extended by the directors of the Company (the "Directors") to no later than 30 September 2014.

Β 

The Finance Bill 2014 (the "Bill"), published on 27 March 2014, contained proposed changes to regulations which would apply to VCT shares issued on or after 6 April 2014.Β The Directors have been advised that certain provisions of the Bill are ambiguous and, if an allotment were to be made subsequent to 6 April 2014, could be interpreted in a manner that would have serious and adverse tax consequences for all Shareholders. Although HM Treasury have acknowledged the concerns made by the VCT industry regarding these provisions, and have agreed that amendments will be made to them, the relevant amendments have not yet been published. Any amendments will also be subject to Parliamentary review and debate.

Β 

Therefore, in the interest of all of the Company's Shareholders, the Directors have decided to postpone any allotment of new Ordinary Shares under the Offer for the 2014/15 tax year, with applications (and application monies) held pending until the Directors believe that there is certainty that allotments can take place without contravening the new rules. At such time when the Directors have been advised that the allotments can be made without adverse effects on the status and operation of the Company, an appropriate announcement will be made.

Β 

Given that the Directors intended to allot Ordinary Shares for the tax year 2014/15 before the end of April 2014, it was the expectation that all new investors under the Offer would be eligible to receive the final dividend from the Company for the year ended 30 November 2013. However, in view of the above, it is possible that any further allotment of new Ordinary Shares may now take place after the record date for this dividend, in which case the Offer Price will be adjusted under the Pricing Formula for the Offer and will reflect that no dividend payment will be received.

Β 

In view of the above, the Offer has been extended to 5.00 pm on 30 September 2014 or such earlier date on which the Offer is fully subscribed or on which the directors of the Companies may resolve to close the Offer. In relation to this issue, it is also proposed that a Supplementary Prospectus will be submitted to the UKLA for approval, at which point a further announcement will be made.

Β 

Any enquiries in respect of this extension to the Offer should be directed to:

Β 

Maven Capital Partners UK LLP:

Telephone: 0141 306 7400

E-mail: enquiries@mavencp.com

Β 

Maven Capital Partners UK LLP

Secretary

Β 

30 April 2014

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
STRLFFFLSFIAFIS
Date   Source Headline
13th Oct 20234:56 pmRNSPublication of a Prospectus
25th Aug 20239:38 amRNSIssue of Equity
21st Aug 20233:28 pmRNSStatement re Dividend Investment Scheme
21st Jul 202312:52 pmRNSHalf-year Report
13th Jul 20234:04 pmRNSTransaction in Own Shares
6th Jul 20234:01 pmRNSStatement re Intended Offers for Subscription
30th Jun 20234:22 pmRNSNet Asset Value and Interim Dividend
2nd Jun 20239:41 amRNSIssue of Equity
27th Apr 20231:04 pmRNSIssue of Supplementary Prospectus
26th Apr 202310:15 amRNSIssue of Equity - Dividend Investment Scheme
24th Apr 202312:51 pmRNSResult of AGM
19th Apr 20234:49 pmRNSTransaction in Own Shares
19th Apr 20231:05 pmRNSNet Asset Value - Dividend Investment Scheme
5th Apr 202312:29 pmRNSIssue of Equity
4th Apr 202311:43 amRNSNet Asset Value(s)
29th Mar 20232:19 pmRNSIssue of Supplementary Prospectus
14th Mar 20234:31 pmRNSAnnual Financial Report
3rd Mar 20239:53 amRNSIssue of Equity
21st Feb 20234:41 pmRNSTransaction in Own Shares
16th Feb 20237:00 amRNSStatement re Offer for Subscription
8th Feb 202311:06 amRNSDirector/PDMR Shareholding - Replacement
8th Feb 202310:19 amRNSDirector/PDMR Shareholding
8th Feb 202310:19 amRNSDirector/PDMR Shareholding
8th Feb 202310:08 amRNSDirector/PDMR Shareholding
8th Feb 20239:43 amRNSIssue of Equity
1st Feb 20233:23 pmRNSUnaudited NAV and Proposed Final Dividend
12th Dec 20223:41 pmRNSDirectorate Change
12th Dec 20223:34 pmRNSStatement re Director's Other Quoted Directorships
9th Nov 20223:00 pmRNSResult of General Meeting
4th Nov 20222:35 pmRNSTransaction in Own Shares
31st Oct 20223:54 pmRNSTransaction in Own Shares
21st Oct 20222:45 pmRNSNet Asset Value(s)
7th Oct 20224:28 pmRNSPublication of a Prospectus
4th Oct 20223:30 pmRNSChange of Auditor
26th Aug 202210:04 amRNSIssue of Equity
22nd Aug 20229:33 amRNSStatement re Dividend Investment Scheme
29th Jul 202211:25 amRNSHalf-year Report
21st Jul 20224:38 pmRNSTransaction in Own Shares
13th Jul 202211:19 amRNSNet Asset Value and Interim Dividend
8th Jul 20223:28 pmRNSStatement re Joint Offers for Subscription
6th Jun 20222:15 pmRNSIssue of Equity
26th May 20225:02 pmRNSTransaction in Own Shares
26th Apr 202212:34 pmRNSIssue of Supplementary Prospectus
26th Apr 202210:51 amRNSIssue of Equity - Dividend Investment Scheme
21st Apr 20222:39 pmRNSStatement re Dividend Investment Scheme
6th Apr 20224:02 pmRNSNet Asset Value(s)
6th Apr 20221:45 pmRNSResult of AGM
5th Apr 20226:30 pmRNSIssue of Equity
23rd Mar 20225:10 pmRNSDirector/PDMR Shareholding
23rd Mar 20225:05 pmRNSIssue of Equity

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.